���构特征与受体作用机制 — 2026 Update

By Editorial Desk · published 2026-01-15 · last reviewed 2026-02-05 · Wiki

A practical reference on mass spectrometry: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-02-05. Anything still debated is marked as such rather than presented as settled.

结构特征与受体作用机制

序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。

Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物，其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代，使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸，进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链，该侧链赋予分子与血浆白蛋白结合的能力。

该分子作为 GLP-1 受体的选择性激动剂发挥作用，受体属于 B 类 G 蛋白偶联受体家族，激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞，信号促进葡萄糖依赖性的胰岛素释放，血糖偏低时该作用明显减弱。在胰岛 α 细胞，胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达，相应信号参与食欲调节以及胃排空速率的降低。

Handling, Storage, and Analytical Verification

Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.

Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.

Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.

Semaglutide at a glance

Background and Molecular Profile

Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.

Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.

The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.

Related pages on this site

• Measured index
• Simple review
• Optimized review
• Quality dataset
• Robust playbook
• Modern collection
• Focused trends
• Quality playbook

Background and Molecular Design

The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.

Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.

Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.

Background and Mechanism of Action

Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.

Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.

Reference notes

Opioid-induced hyperalgesia – where individuals using opioids to relieve pain paradoxically experience more pain as a result of that medication – has been observed in some people. This phenomenon, although uncommon, is seen in some people receiving palliative care, most often when dose is increased rapidly. If encountered, rotation between several different opioid pain medications may decrease the development of increased pain. Opioid induced hyperalgesia more commonly occurs with chronic use or brief high doses, but some research suggests that it may also occur with small doses. Side effects such as hyperalgesia and allodynia, sometimes accompanied by a worsening of neuropathic pain, may be consequences of long-term treatment with opioid analgesics, especially when increasing tolerance has resulted in loss of efficacy and consequent progressive dose escalation over time. This appears to largely be a result of actions of opioid drugs at targets other than the three classic opioid receptors, including the nociceptin receptor, sigma receptor and Toll-like receptor 4, and can be counteracted in animal models by antagonists at these targets such as J-113,397, BD-1047 or (+)-naloxone respectively. No drugs are currently approved specifically for counteracting opioid-induced hyperalgesia in humans and in severe cases the only solution may be to discontinue use of opioid analgesics and replace them with non-opioid analgesic drugs.

In biochemistry, a cross-linked enzyme aggregate is an immobilized enzyme prepared via cross-linking of the physical enzyme aggregates with a difunctional cross-linker. They can be used as stereoselective industrial biocatalysts.

=== Detransition === Some transgender people may be forced to medically detransition and stop gender-affirming medical treatment due to discriminatory laws being passed in their country or state that ban access to gender-affirming health care. In rare cases, individuals may decide to cease or reverse gender-affirming medical therapy voluntarily. Reasons can include physical adverse effects, changing view of gender identity, and social rejection/discrimination. Research is very limited into the process of detransitioning. According to the International Journal of Transgender Health, the recommendation is to consult a team of providers in diverse specialties on how to proceed with the detransition process.

Sources: en.wikipedia.org

Reference notes

== Further reading == Coluzzi F, Mattia C (July–August 2005). "Oxycodone. Pharmacological profile and clinical data in chronic pain management" (PDF). Minerva Anestesiologica. 71 (7–8): 451–460. PMID 16012419. Archived from the original (PDF) on March 9, 2006.

=== November === 1 November – Sinn Féin and the Social Democratic and Labour Party say they will support a motion of no confidence in Paul Givan, Stormont's Education Minister, after he took part in a six-day visit to Israel along with other unionist politicians. 2 November – Former SNP Cabinet Secretary for Health Jeane Freeman blames failures faced by NHS Scotland on successive governments including her own. 4 November – In a pre-budget speech from Downing Street, Chancellor Rachel Reeves Chancellor Rachel Reeves says she will make "necessary choices" in the forthcoming budget after the "world has thrown more challenges our way". 5 November – MSPs vote 85–25 in favour of the Land Reform (Scotland) Bill that aims to reduce the concentration of rural land ownership among a small number of people. Charges against former SDLP leader Colum Eastwood in relation to his attendance at a pro-Palestine rally are dropped after he accepted a formal caution. 6 November – Culture Secretary Lisa Nandy is found to have "unknowingly" breached public appointment rules with her choice to be the boss of England's new football watchdog. 7 November – The Labour Whip is restored to Chris Hinchliff, Neil Duncan-Jordan, Brian Leishman and Rachael Maskell following their suspension for voting against the government's Welfare Reform Bill in July. Deputy First Minister of Northern Ireland Emma Little-Pengelly turns down an invite to the inauguration of President of Ireland Catherine Connolly.

Starting in 2001, the government introduced a series of programmes to increase fertility, including paid maternity leave, childcare subsidies, tax relief and rebates, one-time cash gifts, and grants for companies that implement flexible work arrangements; nevertheless, live births have continued to decline, hitting a record low in 2022. Singapore's immigration policy is designed to alleviate the decline and maintain its working-age population. 91% of resident households (i.e. households headed by a Singapore citizen or permanent resident) own the homes they live in, and the average household size is 3.43 persons (which include dependants who are neither citizens nor permanent residents). However, due to scarcity of land, 78.7% of resident households live in subsidised, high-rise, public housing apartments developed by the Housing and Development Board (HDB). Also, 75.9% of resident households live in properties that are equal to, or larger than, a four-room (i.e. three bedrooms plus one living room) HDB flat or in private housing. Live-in foreign domestic workers are quite common in Singapore, with about 224,500 foreign domestic workers there, as of December 2013.

Driver, who is incarcerated at Salinas Valley State Prison (CDCR #D-35391), has filed numerous pro se civil rights actions under 42 U.S.C. § 1983 at multiple California facilities. While his lawsuits have consistently been dismissed on procedural grounds, he has appealed some decisions to the U.S. Court of Appeals for the Ninth Circuit. In May and June 2022, Adilah Patton, a 28‑year‑old pretrial detainee in Indianapolis, was forcibly injected twice with Invega Sustenna while in custody at the Marion County Adult Detention Center. A federal lawsuit filed on her behalf alleges that the injections were administered without a medical assessment, a prescription, or the consent of her court‑appointed guardian. The lawsuit describes the injections as assault, battery, excessive force, and violations of the Fourteenth Amendment right to informed consent. In September 2024, Haitian immigrant Cassandra Fameux filed a criminal complaint alleging that her husband, Michigan anesthesiologist Dr. Paul Gregory St. Claire, and psychiatrist Dr. Dominic Barberio forcibly injected her monthly from 2017 to 2021 with unprescribed Invega Sustenna—sometimes at doses up to 256 mg—as "punishment" when her husband was angry. Divorce court testimony and a recorded conversation indicate Barberio admitted she was not schizophrenic; two psychiatrists found she had PTSD, not bipolar disorder or schizophrenia. A subsequent police investigation led to a recommendation that her husband be charged with domestic assault.

Sources: en.wikipedia.org

Notes from published material

Side effects are generally similar to other antipsychotics. The drug has a relatively well tolerated side effect profile, with low propensity for QTc interval changes, weight gain and lipid-related adverse effects. In a 2013 meta-analysis of the efficacy and tolerability of 15 antipsychotic drugs, it was found to produce the second least (after haloperidol) weight gain, the least QT interval prolongation, the fourth most extrapyramidal side effects (after haloperidol, zotepine and chlorpromazine), and the sixth least sedation (after paliperidone, sertindole, amisulpride, iloperidone and aripiprazole). As with other atypical neuroleptics, lurasidone should be used with caution in the elderly because it puts them at an increased risk for a stroke or transient ischemic attack; however, these risks are not likely to be greater than those associated with antipsychotics of other classes. Similarly, lurasidone should not be used to treat dementia-related psychosis, as evidence has shown increased mortality with antipsychotic use. Weight gain is reported in up to 15 and 16 percent of users. Other possible side effects include vomiting, akathisia, dystonia, parkinsonism, somnolence, dizziness, sedation and nausea.

do not correspond to mutations and can be left unfilled. In addition to these counts, data on the mutability and the frequency of the amino acids was obtained. The mutability of an amino acid is the ratio of the number of mutations it is involved in and the number of times it occurs in an alignment. Mutability measures how likely an amino acid is to mutate acceptably. Asparagine, an amino acid with a small polar side chain, was found to be the most mutable of the amino acids. Cysteine and tryptophan were found to be the least mutable amino acids. The side chains for cysteine and tryptophan have less common structures: cysteine's side chain contains sulfur which participates in disulfide bonds with other cysteine molecules, and tryptophan's side chain is large and aromatic. Since there are several small polar amino acids, these extremes suggest that amino acids are more likely to acceptably mutate if their physical and chemical properties are more common among alternative amino acids.

=== Sao Penza === The South African-made model was exported to the United Kingdom between 1991 and 1993 as the "Sao Penza" and fitted with a 1.3-litre fuel-injected engine. The importer was Automotive Holdings, a subsidiary of Mazda Cars Ltd, the official Mazda UK importer. It was a rebadged version of the Mazda 323, imported from South Africa, where the 1985 model was still assembled by Samcor (now Ford Motor Company of South Africa), although it had ceased to be imported to the UK in 1989. Both four-door saloon and five-door hatchback versions were available, with fairly basic specifications. It went on sale in the United Kingdom in June 1991, with around 1,200 vehicles expected to be sold within six months. Marketed as "Japanese technology you can afford", it was sold at just over £7,500 – around £2,000 cheaper than the equivalent version of the new Mazda 323. However, it struggled to compete in a segment of the market dominated by South Korean and Eastern European models. Its prices, which were reduced in early 1992, were not low enough to attract strong sales and it was withdrawn from sale in 1993. Just over 1,000 were sold and by 2019, DVLA records showed that there was just one example remaining in use (a blue 1.3L 5-door) The car uses the 1.3 L (1,324 cc) Mazda B3 four-cylinder engine. Maximum power is 65 hp (48 kW) at 5500 rpm, providing a top speed of 150 km/h (93 mph).

=== Escherichia coli === A popular system utilized is Escherichia coli because of its rapid growth rate (~20–30 minutes), capacity for continuous fermentation and relatively low cost. Additionally, yeast has the capacity to express a high relative volume of heterologous protein. Specifically, up to 30% of proteins produced in yeast can be the heterologous gene product. There also are safe strains of E. coli that have been successfully generated to scale up production. In addition to E. coli's attractive host properties, this host is incredibly popular due to researchers having a large amount of knowledge about its genetics, including the complete genomic sequence. However, issues arise either due to the sequence of the gene of interest and those that are due to the limitations of E. coli as a host. For example, proteins expressed in large amounts in E.coli tend to precipitate and aggregate, which then requires another denaturation, renaturation recovery method. Finally, E. coli is only optimally effective in specific conditions dependent on the gene being inserted.

== Description == Pileas: The cap is 15–55 mm (0.6–2.2 in) in diameter and conic to obtusely conic to convex. The cap margin is turned inwards when young, rarely becoming plane in age, often distinctly rippled, translucent-striate and bruising and aging greenish-bluish about the margin. It is dark olive brown to buff brown in color, occasionally steel blue; when dried it tends toward copper brown in the center. It is hygrophanous, fading to milk white, and viscid when moist from a gelatinous pellicle, usually separable. The flesh is thin and bruises blue easily. Gills: The gills are close with adnate to sinuate attachment and are grayish to cinnamon brown, with the edges remaining pallid. Spore Print: dark purplish brown Stipe: The stipe is 5–7 cm (2.0–2.8 in) long, 2–3 mm (0.1–0.1 in) thick, and equal to subequal. The color is pallid to brownish with white filaments, while often more yellowish towards the apex. Distinct rhizomorphs are found at the base. The stipe is brittle, stuffed with loose fibers, and the partial veil is evanescent and rapidly becomes indistinguishable. Taste: farinaceous Odor: farinaceous Stain: It stains blue easily where damaged.

Sources: en.wikipedia.org

Frequently asked questions